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Abstract
I In nt tr ro od du uc ct ti io on n: : The aim of the research was to assess whether concentrations of
inflammatory markers in blood of patients after cardiac arrest (CA) are related
to their clinical state and survival. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Forty-six patients, aged 63 ±12 years, 21 of them after
out-of-hospital CA and 25 after in-hospital CA, were enrolled in the study. 
Twenty-five patients survived and were discharged from hospital (CA-S); 21 died
during hospitalization (CA-D). The clinical state of the patients was evaluated
by the Glasgow Coma Scale (GCS) and the Acute Physiology and Chronic Health
Evaluation II (APACHE II). On the day immediately after CA (day 1) and on the
following day (day 2) the plasma concentration of high specific C-reactive protein
(hs-CRP), tumour necrosis factor (TNF)-ʱ, interleukin-10 and interleukin-6 (Ile-6)
were measured. 
R Re es su ul lt ts s: :    In  CA-D  patients,  compared  with  CA-S,  a significantly  higher
concentration of hs-CRP (on day 1, 19 ±5 vs. 15 ±4; on day 2, 21 ±3 vs. 16 ±5 mg/l,
p < 0.001) and Ile-6 (on day 1, 24.9 ±19.8 vs. 9.2 ±11.3; on day 2, 24.2 ±19.7 vs.
6.9 ±6.8 IU/ml, p < 0.001) was found. The level of TNF-ʱ was greater in CA-D on
day 1 (0.42 ±0.75 vs. 0.18 ±0.21 IU/ml, p < 0.04). Concentrations of hs-CRP and
Ile-6 were correlated with the scores of GCS and APACHE II. Using logistic
regression analysis and ROC curves the prognostic value of hs-CRP and Ile-6 for
survival was proven. 
C Co on nc cl lu us si io on ns s: :   Post-cardiac arrest immuno-inflammatory response, reflected mainly
in elevated plasma concentration of hs-CRP and Ile-6, is not only correlated with
patients’ clinical state but also with prediction of survival. 
K Ke ey y   w wo or rd ds s: :   cardiac arrest, post-cardiac arrest syndrome, survival, interleukin, 
C-reactive protein.
Introduction
Cardiac arrest (CA), the sudden cessation of effective cardiac pumping
function [1], is still a major clinical problem with a high rate of early and
long-term mortality [2, 3]. 
Since 1960, when Kouwenhoven described the technique of closed-
chest cardiac massage and defibrillation in patients with CA [4], and 1966,
when  the  first  original  consensus  statement  on  cardiopulmonary
resuscitation [5] was published by the National Academy of Sciences –
National  Research  Council  Ad  Hoc  Committee  on  Cardiopulmonary
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Resuscitation, despite introducing novel resus  -
citation methods over recent decades, no significant
progress in survival following successful cardio  -
pulmonary resuscitation of in-hospital and out-of-
hospital CA has been made [2, 6, 7]. It pinpoints
that further enhancement of survival after CA may
be achieved by focusing on the vitally important
pathophysiological  state  after  resumption  of
spontaneous circulation, which should be more
thoroughly studied and treated [2].
It  was  Negovsky  who,  in  the  early  1970s,
recognized the pathology caused by complete
whole-body ischaemia [8], the so-called post-CA
syndrome, a complex combination of possible brain
injury,  myocardial  dysfunction  and  systemic
ischaemia/reperfusion response, which implies
activation of coagulation and immunologic path  -
ways, increasing the risk of multiple organ failure
and infection [2, 9, 10]. 
Very few studies have tried to determine the role
for survival of systemic inflammatory response in
the intermediate phase after CA, i.e. ranging from
6-12 until 72 h after CA [2, 11, 12]. Of these studies,
the research of Adrie et al. on the role of interleukins
in this period is particularly unique [11]. This is why
the first aim of our research was to assess the
possible relationship between concen  tration of
markers of the immuno-inflam  matory response and
survival of patients in the inter  mediate phase after
CA. The second aim was to evaluate the relationship
between levels of the aforementioned markers and
the patients’ clinical state after CA.
Material and methods
The study was approved by the Bioethics Com  -
mittee of the Medical University of Lodz with no
requirement of informed patient consent due to their
severe clinical state or unconsciousness after CA. 
P Pa at ti ie en nt ts s
We  enrolled  46  consecutive  patients  with
a mean age of 63 ± 12 years, 31 men and 15 women,
hospitalized directly after CA in the Department of
Anaesthesiology and Intensive Care Therapy or in
the Intensive Care Unit of the Department of
Cardiology of the First Chair of Cardiology and
Cardiac Surgery of the Medical University of Lodz
in 2005. Fourty-five percentage of the patients
suffered out-of-hospital and 55% in-hospital CA.
The mechanism of CA was ventricular fibrillation or
pulseless ventricular tachycardia in 78% of the
patients and asystole or pulseless electrical activity
in 22%. In 43 patients CA occurred during acute
coronary syndrome, in 1 due to dilated cardio  -
myopathy,  and  in  2  it  was  caused  by  severe
respiratory insufficiency. Detailed information on
the patients is available in Table I. In the first 24 h
D Da at ta a P Pa at ti ie en nt ts s   a af ft te er r   C CA A C CA A- -S S   v vs s. .   C CA A- -D D
C CA A- -S S   ( (n n = =   2 25 5) ) C CA A- -D D   ( (n n = =   2 21 1) ) V Va al lu ue e   o of f   p p
Age [years] 62.6 ±10.6 (47-80) 64.2 ±13.3 (34-89) NS
No. of men [n (%)] 17 (68%) 14 (67%) NS
IHCA [n (%)] 16 (64%) 10 (48%) NS
OHCA [n (%)] 9 (36%) 11 (52%) NS
VF/VT [n (%)] 21 (84%) 10 (48%) 0.01
Asystole/PEA [n (%)] 4 (16%) 11 (52%) 0.01
Comorbidities:
Diabetes [n (%)] 9 (36%) 2 (10%) 0.04
Hypertension [n (%)] 18 (72%) 11 (52%) NS
Myocardial infarction [n (%)] 9 (36%) 7 (33%) NS
Severe heart failure [n (%)] 1 (4%) 3 (14%) NS
Stroke [n (%)] 2 (8%) 4 (19%) NS
COPD [n (%)] 3 (12%) 5 (24%) NS
GCS [score] 9 ±5 (3-15) 5 ±3 (3-13) 0.005
APACHE II [score] 21 ±10 (5-39) 28 ±2 (8-41) 0.02
CA – cardiac arrest, CA-S, CA-D – patients after CA who survived hospitalization and were discharged from hospital, ones who died in hospital,
respectively, No. of men – number of men in the group, IHCA – patients who suffered in-hospital cardiac arrest, OHCA – patients who suffered
out-of-hospital cardiac arrest, VT/VF, asystole/PEA – patients with CA due to ventricular fibrillation or ventricular tachycardia, or due to asystole
or pulseless electrical activity, COPD – chronic obstructive pulmonary disease, GCS – Glasgow Coma Scale, APACHE II – Acute Physiology and
Chronic Health Evaluation II, NS – non-significant
T Ta ab bl le e   I I. . Selected clinical information on patients who survived hospitalization and were discharged from hospital
and patients who died in hospitalArch Med Sci 4, August / 2011 621
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after  CA,  cardiogenic  shock  was  observed  in 
5 patients. The appropriate treatment, including
percutaneous coronaroplasty, intra-aortic balloon
pumping,  mechanical  ventilation  and  suitable
pharmacology,  was  used  for  all  the  patients.
Hypothermia or coronary artery bypass grafting was
not applied. Patients in whom CA occurred in the
final stages of chronic wasting diseases or CA was
related to mechanical trauma were not included in
the study.
On the first day of hospitalization 2 patients
died, on the second day 1 patient, and on the third
day 2 patients. Finally, 2 groups were created: 
21 patients who died during hospitalization (CA-D)
and 25 patients who survived and after achieving
optimally stable function of all vital organs and
systems were discharged from the intensive care
unit (CA-S). Most CA-S patients were discharged
home; some of them were transferred to another
facility  due  to  individual  need  of  additional
treatment, all of them on spontaneous respiration,
without circulatory support and in a good neuro  -
logical state.
M Me et th ho od ds s   o of f   d da at ta a   c co ol ll le ec ct ti io on n
At 8.00 a.m. on the day following the CA (day 1)
and the next day (day 2) the clinical state of the
patients after CA was determined by means of the
Glasgow Coma Scale (GCS), assessing the state of
the central nervous system [13, 14], and Acute
Physiology  and  Chronic  Health  Evaluation  II
(APACHE II), describing the general clinical state [13,
15, 16]. Values of the scales of the patients after CA
are exhibited in Table II. 
Blood venous samples were taken from the
patients of both groups at 8.00 a.m. on day 1, i.e.
4-16 h after CA, and on day 2, i.e. after a further 
24 h. From these samples, morphologic para  me  -
ters of blood, including white blood count (WBC),
were evaluated (for this purpose we employed 
ABX Micros 60 Haematology System, produced 
by Horiba ABX, France, and required reagents: 
ABX  Lysebio,  ABX  Monoclair,  ABX  Eosinofix, 
ABX Basolyse II and ABX Diluent). Other typical
biochemical parameters, not mentioned in the rest
of this article, were also measured.
The  blood  samples  were  centrifuged  at
rotational speed of 4000 rpm for 1 min using
a high-speed  brushless  centrifuge  (MPW-350,
produced by MPW Med. Instruments, Poland). The
plasma  samples  recovered  in  this  way  were
immediately frozen at –70°C. Using enzyme-linked
immunosorbent assay (ELISA) and a microplate
reader (Microplate Reader Model ʣ 960, produced
by Metertech Inc., Taiwan) we determined the
plasma concentration of the following parameters
related to the inflammatory state: high sensitivity
C-reactive protein (hs-CRP), tumour necrosis factor
ʱ (TNF-ʱ), interleukin-6 (Ile-6) and interleukin-10
(Ile-10). For assessing their levels we used a high-
sensitivity enzyme immuno  assay for the quanti  -
tative determination of C-reactive protein (CRP)
concentration in human plasma (produced by DRG
International, Inc., USA), and 3 kits for determining
the concentrations of interleukins: Human IL-6
Immunoassay, Human IL-10 Immuno  assay and
Human TNF-ʱ/TNFSF1A Immunoassay (manu  fac  -
tured by R&D Systems, Inc., USA). 
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
Parameters  composed  of  quantitative  data
collected from patients of CA-D and CA-S were
analysed for being of normal distribution by the
Shapiro-Wilk test. For comparison of the parameters
of normal distribution in both groups, a t-test and
relative to it the Cochran-Cox test were employed,
depending on the results of the comparison of the
variations assessed by Levene’s test. The Mann-
Whitney  test  was  used  for  comparison  of
quantitative data of parameters with non-normal
distribution  in  any  of  the  two  groups  being
compared.  For  comparison  of  parameters  of
qualitative value between the groups, placed in
a two-by-two  occurrence  array,  depending  on 
the expected value and the total number of the
sample being analysed, ˇ2 test, ˇ2 test with Yates
CA – cardiac arrest, GCS – Glasgow Coma Scale, APACHE II – Acute Physiology and Chronic Health Evaluation II, CA-S, CA-D – patients after CA
who survived hospitalization and were discharged from hospital, ones who died in hospital, respectively, day 1 – the day following the day of
CA, day 2 – the day after day 1, NS – non-significant 
T Ta ab bl le e   I II I. .   Clinical state of patients who survived hospitalization and patients who died in hospital on 2 consecutive
days after cardiac arrest, evaluated by means of the Glasgow Coma Scale and Acute Physiology and Chronic Health
Evaluation II
S Sc ca al le e D Da ay y   a af ft te er r   C CA A P Pa at ti ie en nt ts s   a af ft te er r   C CA A C CA A- -S S   v vs s. .   C CA A- -D D
C CA A- -S S C CA A- -D D V Va al lu ue e   o of f   p p
GCS Day 1 12 ±4 (3-15) 7 ±5 (3-15) 0.001
Day 2 13 ±4 (3-15) 6 ±5 (3-15) 0.0001
APACHE II Day 1 12 ±9 (2-27) 23 ±9 (3-37) 0.0004
Day 2 12 ±10 (2-34) 15 ±11 (2-30) NS622 Arch Med Sci 4, August / 2011
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correction, V-squared test or Fisher exact test was
employed. 
A statistical hypothesis, H0, assuming no dif  fe  -
rence in the value or occurrence of a parameter
between the groups, and an alternative hypothesis,
H1, assuming a significant difference, were put forth.
As the significant value of statistical significance
(p) to reject H0 and to accept H1, a level below 0.05
was accepted. 
The relationship of the quantitative parameters
with scores of GCS and APACHE II in the 2 days
after CA was determined by calculating Spearman’s
rank correlation coefficient. 
To assess a possible correlation between the
parameters mentioned above (independent varia  -
bles) and demise or survival after CA (dependent
dichotomic variable) we created univariate models
by means of logistic regression analysis (LRA). For
each independent variable, the regression coef  -
ficient with its statistical significance and odds ratio
was  calculated,  assuming  a 95%  confidence
interval. 
The appraisal of possible association between
the parameters of immuno-inflammatory state
(independent variables) and the outcome of CA
(dependent dichotomic variable) was also per  -
formed using receiver operating characteristic (ROC)
curves, determining the area under the curve (AUC)
and the cut-off point, the value of a para  meter that
reveals  optimal  sensitivity  and  specificity  for
predicting the outcome of CA with the highest
accuracy. After assessing the shape of the ROC
curve, an evident relationship between the variables
was recognized arbitrarily when AUC was greater
than 0.75 and the lower limit of the 95% confidence
interval for AUC was above 0.5. 
For computed mathematical calculations Sta  tis  -
tica 8 Pl software was employed (produced by
StatSoft Inc, USA).
Results
Due to a graver clinical state the patients who
died after CA revealed lower scores of GCS and
higher  ones  of  APACHE  II  than  patients  who
survived hospitalization (Table II).
In CA-D, compared with CA-S, significantly higher
concentrations of hs-CRP and Ile-6 on day 1 and 
day 2 were noted (Table III). The concentration of 
TNF-ʱ was  significantly  higher  in  CA-D  only 
on day 1. There was no significant difference in
concentration of Ile-10 and WBC between CA-D 
and CA-S. 
I In nf fl la am mm ma at to or ry y   r re es sp po on ns se e   a an nd d   c cl li in ni ic ca al l   s st ta at te e
A significant correlation between the clinical state
of the patients after CA and the parameters of
inflammatory state was found (Table IV). Concen  -
trations of hs-CRP and Ile-6, measured on day 1 and
day 2, were negatively correlated with the score of
GCS and positively with the values of APACHE II,
assessed on both days. The level of TNF-ʱ on day 1
was negatively correlated with scores of GCS and
positively with values of APACHE II on day 1 and 
day 2. The concentration of TNF-ʱ on day 2 was
negatively  correlated  with  scores  of  GCS  and
positively with values of APACHE II assessed on 
day 1. The level of Ile-10 on day 2 was positively
correlated with the score of APACHE II on the 
same day. 
Using GCS and APACHE II, no significant dif  -
ference in WBC between CA-D and CA-S (Table III),
CA – cardiac arrest, CA-S, CA-D – patients after CA who survived hospitalization and were discharged from hospital, ones who died in hospital,
respectively, day 1 – the day following the day of CA, day 2 – the day after day 1, NS – non-significant, hs-CRP – high-sensitivity C-reactive protein,
TNF-ʱ – tumour necrosis factor ʱ, Ile-6 – interleukin-6, Ile-10 – interleukin-10, WBC – white blood count
T Ta ab bl le e   I II II I. .   Values of the parameters involved in immune-inflammatory response after cardiac arrest in patients who
survived hospitalization and patients who died in hospital
P Pa ar ra am me et te er r D Da ay y   a af ft te er r   C CA A P Pa at ti ie en nt ts s   a af ft te er r   C CA A C CA A- -D D   v vs s. .   C CA A- -S S
C CA A- -S S C CA A- -D D V Va al lu ue e   o of f   p p
hs-CRP [mg/l] Day-1 15±4 (6.6-22.4)  19 ±5 (7.0-24.4) 0.001
Day-2 16±5 (3.4-22.7)  21 ±3 (13.1-24.8) 0.0007
Ile-6 [IU/ml] Day-1 9.2±11.3 (0.4-47.4)  24.9 ±19.8 (2.14-54.8) 0.001
Day-2 6.9 ±6.8 (0.21-24.7)  24.2 ±19.7 (2.53-54.1) 0.001
Ile-10 [IU/ml] Day-1 0.50 ±1.21 (0.0-4.41) 0.48 ±0.91 (0.0-3.61) NS
Day-2 0.21 ±0.59 (0.0-2.73) 0.32 ±0.66 (0.0-2.53) NS
TNF-ʱ [IU/ml] Day-1 0.18 ±0.21 (0.0-0.83) 0.42 ±0.75 (0.0-3.46) 0.04
Day-2 0.18 ±0.18 (0.0-0.56) 0.47 ±0.99 (0.04-4.24) NS
WBC [109/l] Day-1 13.9 ±4.3 (9.0-21.7) 11.5 ±4.3 (4.3-21.3) NS
Day-2 11.9 ±4.0 (8.6-14.3) 12.4 ±4.8 (3.3-18.3) NSArch Med Sci 4, August / 2011 623
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nor a significant correlation between WBC and the
scores of the scales assessing clinical state after CA
was observed (Table IV). 
I In nf fl la am mm ma at to or ry y   r re es sp po on ns se e   a an nd d   s su ur rv vi iv va al l   a af ft te er r
c ca ar rd di ia ac c   a ar rr re es st t
In the univariate model created by means of
logistic regression analysis, a significant correlation
of concentrations of hs-CRP and Ile-6 as continuous
variables  with  the  outcome  of  CA  was  found 
(Table V). Prognostic value for survival of levels of
these parameters of immuno-inflammatory state
on both days was also proven after assessing the
ROC curves (Figures 1-4), with AUC above 0.75 and
calculated cut-off points revealing good sensitivity,
specificity and accuracy. 
Discussion
Not many previous studies have been devoted
to the post-cardiac arrest inflammatory response
[2, 11, 12]. Adrie et al. [11] in their exceptional study
showed a marked increase in plasma cytokines of
patients  successfully  resuscitated  after  CA,
especially in non-survivors. But it is our research
where the differences in the blood concentration of
immuno-inflammatory markers in the intermediate
GCS – score of Glasgow Coma Scale, APACHE II – score of Acute Physiology and Chronic Health Evaluation II, day 1 – the day following the day
of CA, day 2 – the day after day 1, hs-CRP, TNF-ʱ, Ile-6, Ile-10 – concentration of high-sensitivity C-reactive protein, tumour necrosis factor ʱ,
interleukin-6 and interleukin-10, respectively, WBC – white blood count 
T Ta ab bl le e   I IV V. .   Correlations among clinical state of all patients after cardiac arrest, described by the Glasgow Coma Scale
and Acute Physiology and Chronic Health Evaluation II, and values of the parameters associated with post-resuscitation
inflammatory reaction, expressed by means of Spearman’s rank correlation coefficients
P Pa ar ra am me et te er r    G GC CS S A AP PA AC CH HE E   I II I
D Da ay y   1 1 D Da ay y   2 2 D Da ay y   1 1 D Da ay y   2 2
hs-CRP  Day 1 –0.38 –0.43 0.44 –
Day 2 –0.39 –0.37 0.50 0.33
Ile-6  Day 1 –0.57 –0.53 0.65 –
Day 2 –0.49 –0.51 0.55 0.44
Ile-10 Day 1 –– – –
Day 2 –– –0.41
TNF-ʱ Day 1 –0.34 –0.37 0.38 –
Day 2 –0.37 – 0.39 –
WBC Day 1 –– – –
Day 2 –– – –
Day 1 – the day following the day of cardiac arrest, day 2 – the day after day 1, OR – odds ratio, CI – confidence interval, unit OR (95% CI) – odds
ratio for a unit change in the explanatory variable with 95% confidence interval in brackets, p value of the model – value of the goodness of fit
of ˇ2 statistic of the univariate model, hs-CRP, TNF-ʱ, Ile-6, Ile-10 – concentration of high-sensitivity C-reactive protein, tumour necrosis 
factor ʱ, interleukin-6 and interleukin-10, respectively, WBC – white blood count
T Ta ab bl le e   V V. .   Relations among concentrations of the parameters associated with post-resuscitation inflammatory reaction
and survival after cardiac arrest assessed with univariate model created by logistic regression analysis
P Pa ar ra am me et te er r O OR R   o of f   t th he e   m mo od de el l V Va al lu ue e   o of f   p p t th he e   m mo od de el l U Un ni it t   O OR R   ( (9 95 5% %   C CI I) ) V Va al lu ue e   o of f   p p o of f   t th he e   
p pa ar ra am me et te er r   i in n t th he e   m mo od de el l
hs-CRP On day 1 6.4 0.002 1.25 (1.06-1.48) 0.012
On day 2 7.5 0.0006 1.4 (1.06-1.84) 0.017
Ile-6 On day 1 4.8 0.001 1.07 (1.02-1.12) 0.01
On day 1 4.7 0.0004 1.11 (1.02-1.21) 0.02
Ile-10 On day 2 –– – –
On day 2 –– – –
TNF-ʱ On day 1 –– – –
On day 2 –– – –
WBC On day 1 –– – –
On day 2 –– – –624 Arch Med Sci 4, August / 2011
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phase after CA between patients who died and who
survived after CA have not only been highlighted
and correlated with the clinical state, but proved to
possess prognostic value as well. 
C-reactive protein turned out to be an important
marker of inflammation after CA. Of the enrolled
patients after CA, in the 93% who suffered acute
coronary  syndrome  we  observed  a significant
relationship of elevated concen  tration of hs-CRP
with a poorer state of the central nervous system
and  worse  clinical  state,  as  well  as  with  bad
prognosis. In patients in the first 2 days of acute
myocardial infarction a predictive value of con  -
centration of CRP for survival was documented by
Ziakas et al. [17]. Moreover, Zebrack et al. [18]
ascertained that an increased level of CRP is related
to a higher risk of death or non-death-ended
myocardial infarction in patients with stable and
unstable coronary artery disease.
In this research, the biological mechanism of the
relationship between the level of CRP and survival
after CA was not determined. However, patho  -
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mechanisms mentioned by other authors may be
involved. Satoh et al. [19] found that poorer systolic
function of the left ventricle correlated with increase
in local production of interleukins in the myo  -
cardium, which was influenced by growth of levels
of CRP in patients with dilated cardio  myopathy.
A higher  risk  of  coronary  events  and  greater
mortality associated with expression of adhesion
molecules (ICAM-1) on the walls of coronary arteries
due to an elevated level of CRP was described by
Yeh [20]. 
Ile-6  is  considered  to  be  one  of  the  most
important cytokines of multidirectional activity [21,
22]. It is of little surprise that this interleukin is
involved in the systemic response triggered by such
severe stress as CA-induced whole-body hypoxia
[11]. In our research, a greater concentration of Ile-
6 was strongly correlated with a worse clinical state
of patients after CA. We also demonstrated the
predictive value of an elevated level of Ile-6 for
death after CA. Adrie et al. [11] also described
a higher concentration of Ile-6 in non-survivors than
survivors on the first day after CA. In the available
literature, a high level of Ile-6 is considered to be
associated with an increased number of coronary
events and elevated mortality in patients with acute
coronary syndrome and with stable angina [23-25].
Geppert et al. [26] recognised the level of Ile-6 as
an independent prognostic factor of 30-day survival
in patients suffering acute myocardial infarction
and shock. A poorer prognosis after CA, or in
coronary artery disease, may be due to a correlation
with the concentration of Ile-6 aggravation of
multiorgan dysfunction in cardiogenic and septic
shock, described by Geppert et al. [27].
To sum up, on the basis of the previous research
mentioned above and the results of our study, we
consider the level of CRP and Ile-6 to be prognostic
factors of survival after CA.
It is believed that the main biological function
of Ile-10 is inhibition of the inflammatory response
[28]. Adrie et al. [11] described a higher level of Ile-
10  on  the  first  day  in  post-CA  patients  who
subsequently died. On the second day after CA we
observed a greater mean concentration of Ile-10 in
the patients who died after CA than in the ones
who survived. Moreover, there was a significant
relationship on day 2: the worse the general clinical
state, the higher the concentration of Ile-10. Thus,
we assume that Ile-10 plays a role in the modulation
of the inflammatory response in the later stage of
the post-resuscitation period. We did not prove that
the concentration of Ile-10 may be a prognostic
factor of survival after CA.  
Tumour necrosis factor-ʱ, produced mainly by
blood cells, is an interleukin of pleiotropic activity
[29,  30].  In  patients  after  CA  we  found  the
correlation between an elevated concentration of
TNF-ʱ and a worse state of the central nervous
system, or poorer general state, to be more distinct
on the first day after CA. On that day we also noted
a significantly higher level of TNF-ʱ in the patients
who died than in those who survived. This is why
we suspect that the concentration of TNF-ʱ may
be related to survival in the early post-resuscitation
period despite a lack of proven correlation of 
TNF-ʱ with the outcome of CA in logistic regression
analysis.  The  available  literature  confirms  our
opinion on the vital importance of a TNF-ʱ surge
in critical care; signs of shock [31], impairment 
of  internal  organs  [31]  or  acute  respiratory
insufficiency [30] were described as caused by
a sudden secretion of TNF-ʱ. In the early stage of
the post-resuscitation period, a negative correlation
between the concentration of TNF-ʱ and ejection
fraction of the left ventricle of the heart, known as
an important predictive factor of survival [32], was
described by Niemann [33] in a study on animals.
Leukocytes  are  involved  in  the  damage  of
vascular endothelium and myocardium by means
of an ischaemic-reperfusion mechanism [34], the
phenomenon present in the post-resuscitation
period [12]. An elevated number of leukocytes is
considered to be important for the severely sick,
which is reflected in a higher APACHE II score [15],
describing the general clinical state [13, 15, 16].
Regardless of these facts, we found no correlation of
WBC with either prognosis or clinical state after CA.
In conclusion, the post-cardiac arrest immuno-
inflammatory response, reflected mainly in elevated
plasma concentration of CRP and Ile-6, is not only
correlated with patients’ clinical state but also with
prediction of survival. This suggests that anti-
inflammatory treatment of patients after CA might
become a novel therapeutic approach that has an
impact on the outcome after CA.
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